MediSieve Ltd, the team behind an innovative blood filtration device, are happy to announce the company has received over £1.75 million in funding.

The cash influx has come from a mix of both old and new investors – reflecting the growing confidence in the potential of the device. The medical device company is best known for their magnetic blood filtration technology, a revolutionary new approach to targeting blood-borne diseases by magnetically filtering specific disease-causing components from the bloodstream. The device is being tested for the treatment of Malaria, Sepsis and Leukaemia.

Technology-enabled homecare start-up Cera has raised $17m in Series A funding, just a year and half after launching. 

NVM Private Equity has invested £1.0 million of growth capital into Cambridge-based medical device company Ablatus Therapeutics Limited (“Ablatus”) alongside existing angel investors.

TxCell SA, a developer of cellular immunotherapies based on regulatory T cells (Tregs) for inflammation, autoimmunity and transplantation, today announces it will present its latest manufacturing developments at the 3rd Annual Bioprocessing of Advanced Cellular Therapies Congress to be held in Frankfurt, Germany, on May 29-30, 2018. 

Digital healthcare provider MedicSpot has received investment from a member of Henley Business Angels as part of the SEIS qualifying fund raise. In total MedicSpot is raising £1m in funding and has rapidly closed its oversubscribed £150k SEIS round.

Spherium Biomed has disclosed the top line results of its Phase II clinical trial of Mucomel®, an oral gel for the prevention and treatment of oral mucositis in head and neck cancer patients undergoing chemo/bio-radiotherapy.

Calculus Capital has completed a further investment into a growth capital investment round for Mologic alongside Foresight Group, who led the round.

A doctor who has created an innovative software program to reduce waiting times in A&E has secured a £153,000 investment from NPIF - Mercia Equity Finance, which is managed by Mercia Fund Managers and part of the Northern Powerhouse Investment Fund.

NorthInvest’s Board Director John Fisher has been instrumental to the set up of the Grow MedTech Partnership. 

To support Eagle Genomics’ growth plans, the company has raised $1m within 3 weeks of the launch of its latest investment round, in a first close.

Angel Academe has invested in doppel, a wristband shown to reduce stress. It works by creating a silent vibration on the inside of your wrist which feels just like the ‘lub-dub’ of a heartbeat. Slower rhythms are calming, and faster rhythms help you feel focused – like music. You can use it to stay calm under pressure, focus on the task ahead of you, and keep going when you need to.

Atelerix, a Cambridge and Newcastle, UK-based spin-out from the University of Newcastle and creators of an innovative cell encapsulation technology, closed a round of funding of undisclosed amount.